Indefinite Delivery Contract SPE2DR25D9214

The federal contract IDV award SPE2DR25D9214 is a single-award Indefinite Delivery Contract (IDC) with a ceiling value of $499,999,999, issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract aims to establish a Pharmaceutical Prime Vendor Global Program to provide worldwide pharmaceutical support, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to the Department of Defense (DoD), United States Coast Guard, and other government agencies.

The contract has a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion for the overall program across multiple regional awards. It is a firm fixed-price, requirements-type contract awarded on a lowest price technically acceptable (LPTA) basis, with the intent to make multiple awards to at least three different contractors to ensure resiliency and access to vital pharmaceuticals during contingencies or disasters. The contract covers a wide range of medical needs, including oncology treatments, contraceptives, auto-injectors, and specialized pharmaceutical products, to support the recurring medical supply requirements of military healthcare facilities and veterans' medical centers worldwide.